Rajiv Sinha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rajiv Sinha has a total of 276 co-authors. Here are the top co-authors by number of shared publications:
Shakil Akhtar
Department of Pediatrics, Institute of Child Health, Kolkata, India
17 shared publicationsSubhankar Sarkar
All India Institute of Medical Science, Kalyani, India
13 shared publicationsDeblina Dasgupta
Institute of Child Health, Kolkata, India
12 shared publicationsSushmita Banerjee
Division of Pediatric Nephrology, Institute of Child Health, Kolkata, India
9 shared publicationsNiladri Bose
Institute of Child Health, Kolkata, India
6 shared publicationsSanjukta Poddar
Department of Pediatrics, Institute of Child Health, Kolkata, India
6 shared publications
Latest Publications
- 3 November 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-14
The acute kidney injury – acute kidney disease – chronic kidney disease continuum: pediatric perspective
- 3 November 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-14
The acute kidney injury – acute kidney disease – chronic kidney disease continuum: pediatric perspective
- Open Access
- 2 November 2026
- Published by BMJ in BMJ Paediatrics Open
- Vol. 10 (1) , e005067
Persistent hypogammaglobulinaemia after rituximab in children with difficult-to-treat nephrotic syndrome: a multicentre cross-sectional observational study
- 2 November 2026
- Published by BMJ in BMJ Paediatrics Open
- Vol. 10 (1) , e005067
Open AccessPersistent hypogammaglobulinaemia after rituximab in children with difficult-to-treat nephrotic syndrome: a multicentre cross-sectional observational study
- 15 October 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-11
Pre-transplant evaluation of immunological risk in paediatric kidney transplant recipients
- 15 October 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-11
Pre-transplant evaluation of immunological risk in paediatric kidney transplant recipients
- Open Access
- 27 July 2026
- Published by Elsevier in Kidney International
- Vol. 110 (4) , 1022-1028
A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies
- 27 July 2026
- Published by Elsevier in Kidney International
- Vol. 110 (4) , 1022-1028
Open AccessA multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies
- 26 June 2026
- Published by Elsevier in Kidney International
- Vol. 110 (4) , 1052-1054
COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody–positive immune-complex nephritis
- 26 June 2026
- Published by Elsevier in Kidney International
- Vol. 110 (4) , 1052-1054
COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody–positive immune-complex nephritis
- 30 March 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (4) , e70305
Challenges in Chronic Kidney Disease Management and Kidney Transplantation in a Toddler With Autism Spectrum Disorder
Background: Transplantation in a young child comes with multiple difficulties and the challenge increases in children with intellectual disability disorder such as autism spectrum disorder (ASD). Apart from the usual requirements, these children require detailed planning including ethical considerations as well as strategies for anesthesia and sedation. Method: A male child with bilateral polycystic kidneys secondary to an HNF1B mutation had gastrostomy tube insertion at six months to overcome the challenges of polyuria and failure to thrive. Later, he was diagnosed with ASD and started on cognitive behavioral therapy. Pre‐emptive kidney transplant was planned at three years, with the mother as the donor. On completing the pre‐transplant workup, an anesthetic team and a child psychologist were consulted to discuss the sedation and anesthesia plan. Results: The transplant procedure was uneventful, and the child was shifted to our transplant intensive care unit for planned extubation in the presence of family members. During the perioperative period, initial pain management involved administering a slow infusion of low‐dose morphine with fentanyl. However, he failed initial extubation trials because of agitation, and subsequently, risperidone as well as dexmedetomidine were also introduced. Gradual tapering of medications was performed based on the pain scores. Following the pain management protocol and gradual tapering of medications, he was successfully extubated on day 5 in the presence of his parents and discharged on day 10. Conclusion: The case highlights the challenges associated with transplantation in a young child compounded with additional risks posed by ASD.
- 30 March 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (4) , e70305
Challenges in Chronic Kidney Disease Management and Kidney Transplantation in a Toddler With Autism Spectrum Disorder
Background: Transplantation in a young child comes with multiple difficulties and the challenge increases in children with intellectual disability disorder such as autism spectrum disorder (ASD). Apart from the usual requirements, these children require detailed planning including ethical considerations as well as strategies for anesthesia and sedation. Method: A male child with bilateral polycystic kidneys secondary to an HNF1B mutation had gastrostomy tube insertion at six months to overcome the challenges of polyuria and failure to thrive. Later, he was diagnosed with ASD and started on cognitive behavioral therapy. Pre‐emptive kidney transplant was planned at three years, with the mother as the donor. On completing the pre‐transplant workup, an anesthetic team and a child psychologist were consulted to discuss the sedation and anesthesia plan. Results: The transplant procedure was uneventful, and the child was shifted to our transplant intensive care unit for planned extubation in the presence of family members. During the perioperative period, initial pain management involved administering a slow infusion of low‐dose morphine with fentanyl. However, he failed initial extubation trials because of agitation, and subsequently, risperidone as well as dexmedetomidine were also introduced. Gradual tapering of medications was performed based on the pain scores. Following the pain management protocol and gradual tapering of medications, he was successfully extubated on day 5 in the presence of his parents and discharged on day 10. Conclusion: The case highlights the challenges associated with transplantation in a young child compounded with additional risks posed by ASD.
- 3 February 2026
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (4) , 275-283
Continuous Kidney Replacement Therapy in Pediatric Intensive Care: A Practical Guide for Clinicians
As the complexities of children getting admitted to the pediatric intensive care unit (PICU) are increasing, so is the incidence of acute kidney injury (AKI) as well as the need for performing kidney replacement therapy (KRT). This necessitates special infrastructure as the standard extracorporeal therapy like haemodialysis is often not feasible in these children. Continuous kidney replacement therapy (CKRT) has become the KRT modality of choice in PICUs across high-income countries. Even in emerging economies like India, its use is increasing because of its advantages in critically sick children. This review article summarises the practical aspects of CKRT and serves as a concise guide for postgraduate trainees and intensivists working in the PICU.
- 3 February 2026
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (4) , 275-283
Continuous Kidney Replacement Therapy in Pediatric Intensive Care: A Practical Guide for Clinicians
As the complexities of children getting admitted to the pediatric intensive care unit (PICU) are increasing, so is the incidence of acute kidney injury (AKI) as well as the need for performing kidney replacement therapy (KRT). This necessitates special infrastructure as the standard extracorporeal therapy like haemodialysis is often not feasible in these children. Continuous kidney replacement therapy (CKRT) has become the KRT modality of choice in PICUs across high-income countries. Even in emerging economies like India, its use is increasing because of its advantages in critically sick children. This review article summarises the practical aspects of CKRT and serves as a concise guide for postgraduate trainees and intensivists working in the PICU.
- 11 December 2025
- Published by BMJ in Archives of Disease in Childhood
- Vol. 111 (3) , 283.1-284
Does the presence of bladder debris suggest urine infection in children?
- 11 December 2025
- Published by BMJ in Archives of Disease in Childhood
- Vol. 111 (3) , 283.1-284
Does the presence of bladder debris suggest urine infection in children?
- Open Access
- 9 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Pediatrics
- Vol. 14 (4) , 110374
Impact of glucocorticoid therapy on hypothalamic-pituitary-adrenal axis function in pediatric nephrotic syndrome: A narrative review
Glucocorticoids (GCs) such as prednisolone are widely used in conditions like nephrotic syndrome, asthma, and autoimmune diseases. However, prolonged or high-dose use may suppress the hypothalamic-pituitary-adrenal (HPA) axis, leading to secondary adrenal insufficiency (AI). This condition occurs when the adrenal glands fail to produce adequate cortisol, which is essential for regulating metabolism, immune response, and stress adaptation. Corticotropin-releasing hormone (CRH) from the hypothalamus stimulates the pituitary to release adrenocorticotropic hormone (ACTH), which then triggers cortisol production in the adrenal glands. Prolonged GC use disrupts this system by inhibiting CRH and ACTH secretion, leading to adrenal atrophy and reduced cortisol production. HPA axis suppression is primarily diagnosed through dynamic tests. Early morning cortisol levels above > 18 ng/mL typically indicate normal function, while levels < 3 ng/mL suggest AI. Intermediate values require additional testing, such as the insulin tolerance test, ACTH stimulation test, and metyrapone test. Prednisolone in nephrotic syndrome suppresses the HPA axis, heightening AI risk, influenced by dose, duration, and timing of administration. Careful GC management is essential to balance disease control with risks of HPA axis suppression. Early recognition and timely intervention can prevent adrenal crises and improve outcomes in pediatric patients.
- 9 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Pediatrics
- Vol. 14 (4) , 110374
Open AccessImpact of glucocorticoid therapy on hypothalamic-pituitary-adrenal axis function in pediatric nephrotic syndrome: A narrative review
Glucocorticoids (GCs) such as prednisolone are widely used in conditions like nephrotic syndrome, asthma, and autoimmune diseases. However, prolonged or high-dose use may suppress the hypothalamic-pituitary-adrenal (HPA) axis, leading to secondary adrenal insufficiency (AI). This condition occurs when the adrenal glands fail to produce adequate cortisol, which is essential for regulating metabolism, immune response, and stress adaptation. Corticotropin-releasing hormone (CRH) from the hypothalamus stimulates the pituitary to release adrenocorticotropic hormone (ACTH), which then triggers cortisol production in the adrenal glands. Prolonged GC use disrupts this system by inhibiting CRH and ACTH secretion, leading to adrenal atrophy and reduced cortisol production. HPA axis suppression is primarily diagnosed through dynamic tests. Early morning cortisol levels above > 18 ng/mL typically indicate normal function, while levels < 3 ng/mL suggest AI. Intermediate values require additional testing, such as the insulin tolerance test, ACTH stimulation test, and metyrapone test. Prednisolone in nephrotic syndrome suppresses the HPA axis, heightening AI risk, influenced by dose, duration, and timing of administration. Careful GC management is essential to balance disease control with risks of HPA axis suppression. Early recognition and timely intervention can prevent adrenal crises and improve outcomes in pediatric patients.
- 12 November 2025
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 41 (3) , 402-404
International Pediatric Nephrology Association IgA nephropathy guidelines—a commentary
- 12 November 2025
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 41 (3) , 402-404
International Pediatric Nephrology Association IgA nephropathy guidelines—a commentary